Last updated: February 20, 2026
Zonisamide is a sulfonamide-based anticonvulsant medication used primarily for epilepsy and Parkinson’s disease. It is marketed under brand names such as Zonegran. Several pharmaceutical companies and API (Active Pharmaceutical Ingredient) suppliers manufacture and distribute zonisamide globally.
Major Manufacturers and API Suppliers
1. Sun Pharmaceutical Industries Ltd.
- Produces zonisamide API mainly for the generics market.
- API manufacturing facilities approved by global regulatory agencies such as the FDA and EMA.
- Supplies zonisamide API to generic pharmaceutical companies worldwide.
2. Hetero Drugs Ltd.
- Manufactures zonisamide API.
- API certifications include ISO 9001 and cGMP.
- Supplies both domestic and export markets.
3. MannKind Corporation
- Focuses on inhaled delivery systems but also supplies products related to seizure disorders.
- Involved in R&D for drug delivery of zonisamide.
4. Wockhardt Ltd.
- Manufactures zonisamide API.
- API production is compliant with international standards.
5. Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Based in China.
- Produces zonisamide as part of a broader portfolio of neurology APIs.
- API conforms to Chinese GMP standards and is exported globally.
6. Teva Pharmaceutical Industries Ltd.
- Provides zonisamide in finished dosage form (brand: Zonegran).
- API sources include multiple suppliers, including Asian API manufacturers.
7. Jiangsu Hengrui Medicine Co., Ltd.
- Produces zonisamide API for both domestic and international markets.
- Certified under Chinese GMP standards with export licenses for multiple regions.
Key Considerations
| Aspect |
Details |
| Regulatory Compliance |
Suppliers with approvals from FDA, EMA, or Chinese CFDA preferred. |
| API Quality Standards |
ISO 9001, cGMP, or equivalent certifications are typical benchmarks. |
| Geographic Focus |
Major suppliers are based in India, China, and Israel, serving global markets. |
| Supply Volume |
Suppliers capable of large-scale production for both generic and branded markets. |
Distribution Channels
- Authorized Distributors: Companies like Aurobindo Pharma, Dr. Reddy's Laboratories, and Cipla serve as intermediaries for API and finished formulations.
- Direct Procurement: Large pharmaceutical companies often engage directly with API manufacturers for bulk orders.
- Import/Export Regulations: Suppliers must comply with regional import-export standards, especially for controlled substances regulations where applicable.
Market Trends
- API manufacturing capacity expansion in Asia aligns with increased demand for generics.
- Quality standards for zonisamide suppliers are becoming more stringent, driven by international regulatory requirements.
- Some suppliers focus on biosimilar formulations and novel delivery methods, potentially affecting future supply chains.
Summary
Major zonisamide suppliers include Sun Pharmaceutical, Hetero, Wockhardt, Jiangsu Hengrui, and Zhejiang Hisoar. These companies operate production facilities compliant with GMP standards, primarily serving the global generics and API markets. Finished product supply primarily involves Teva and other multinational companies, with raw API sourced from accredited manufacturers.
Key Takeaways
- The global supply of zonisamide hinges on Asian API manufacturers, with India and China leading.
- Quality certifications like cGMP are critical for supplier credibility.
- Large-scale production capacity supports both generic and branded drug markets.
- Regulatory compliance influences supplier selection and market access.
- Market trends favor capacity expansion and stricter quality controls.
FAQs
Q1: Which companies produce zonisamide API for the global market?
A1: Sun Pharma, Hetero, Wockhardt, Jiangsu Hengrui, and Zhejiang Hisoar.
Q2: What certifications should I look for in a zonisamide API supplier?
A2: cGMP, ISO 9001, and approvals from regulatory agencies such as the FDA or EMA.
Q3: How does regional regulation affect zonisamide suppliers?
A3: Suppliers must navigate regional import-export laws, especially for controlled substances, impacting their market access.
Q4: Are there differences in API quality among suppliers?
A4: Yes, depending on compliance with GMP standards and audit histories. Due diligence is necessary for procurement.
Q5: Which markets are the main consumers of zonisamide?
A5: North America, Europe, and parts of Asia, primarily for epilepsy and Parkinson’s disease treatments.
References
- U.S. Food and Drug Administration. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations.
- European Medicines Agency. (2023). Zonisamide – Summary of Product Characteristics.
- Indian Pharmacopoeia Commission. (2021). API Quality Standards.
- Chinese Pharmacopoeia. (2022). API Specifications for Chinese Manufacturers.
- Market Intelligence Reports. (2023). Global API Manufacturing Industry.
